Gen Ilac Ve Saglik Urunleri Sanayi Ve Ticaret Anonim Sirketi (IST:GENIL)

Turkey flag Turkey · Delayed Price · Currency is TRY
9.67
-0.40 (-3.97%)
At close: Apr 28, 2026
19.57%
Market Cap 43.52B
Revenue (ttm) 19.18B
Net Income (ttm) 814.44M
Shares Out 4.50B
EPS (ttm) 0.15
PE Ratio 63.68
Forward PE n/a
Dividend 0.05 (0.48%)
Ex-Dividend Date Nov 12, 2025
Volume 19,052,700
Average Volume 34,825,615
Open 10.10
Previous Close 10.07
Day's Range 9.67 - 10.17
52-Week Range 7.12 - 14.93
Beta 0.14
RSI 45.60
Earnings Date May 8, 2026

About IST:GENIL

Gen Ilac Ve Saglik Urunleri Sanayi Ve Ticaret Anonim Sirketi, a pharmaceutical company, manufactures and supplies products to treat rare diseases and disorders worldwide. The company offers its products in various areas, such as neurology, endocrinology, nephrology, oncology, hematology, and pediatric. Gen Ilac Ve Saglik Urunleri Sanayi Ve Ticaret Anonim Sirketi has collaboration with Sulfateq BV for the development of molecule SUL-238 as a treatment for Alzheimer's disease and other neurodegenerative diseases. In addition, it manufactures, tra... [Read more]

Sector Healthcare
Founded 1997
Employees 682
Stock Exchange Istanbul Stock Exchange
Ticker Symbol GENIL
Full Company Profile

Financial Performance

In 2025, IST:GENIL's revenue was 19.18 billion, a decrease of -0.59% compared to the previous year's 19.29 billion. Earnings were 814.44 million, an increase of 318.50%.

Financial Statements

News

There is no news available yet.